The role of intellectual property rights in preparing for future pandemics
The global intellectual property framework has been instrumental to developing Covid vaccines, with billions of doses now made every month.
For future pandemics, intellectual property rights will be crucial to building vaccine manufacturing capacity in Africa and elsewhere. This webinar will explore how.
Speakers
Simon Agwale
African Vaccine Manufacturing Initiative, and CEO of Innovative Biotech Ltd, Nigeria
Julie Barnes-Weise
Executive Director, Global Health Innovation Alliance Accelerator, United States
Mark Schultz
Professor of Intellectual Property Law, University of Akron, USA, and Senior Fellow, Geneva Network
Shanker Singham
CEO of Competere and Chairman of Global Economic Neural Networks, United Kingdom